The DMEA (formerly conhIT) took place this year from 9 to 11 April 2019 in Berlin.
GlucoTab was presented at the booth of Cerner as a partner solution. In a live demo the visitors could not only try out the integration of GlucoTab into the clinical workplace of i.s.h.med, but also get a ...
decide Clinical Software GmbH was awarded the Best Pitch Award at the Pitching Days in New York.
decide was one of eight Austrian start-ups which qualified for the event.
More information on the event (in German)
On the occasion of the participation at the Pitching Days 2019 in New York, decide Clinical Software CEO Andreas Krug was interviewed by ORF Styria.
Read more here steiermark.orf.at
As one of eight startups, decide Clinical Software qualified for the multi-day startup bootcamp, which will take place for the third time in New York at the beginning of March 2019: The Pitching Days, organized by Außenwirtschaft Austria in cooperation with Junge Wirtschaft and aws i2 Business Angels.
The event was covered in various media.
Read the Continue Reading →
On 28 and 29 November 2018, the European Innovation Council (EIC) and Medtronic, a leader in the world of medical technology, gathered 20 companies to discuss the transformation of healthcare and promote business partnerships. decide Clinical Software shared its solution “GlucoTab” for blood glucose management.
Small and medium enterprises (SMEs) have been playing an increasingly crucial role in the development of new products in the medical device industry. ...
Participation is supported by the Overseas Trade Fairs Programme under the Horizon 2020 SME Instrument.
Download Article (German)
In a pitch at the life-science-success event on May 10, 2017 the projects had the opportunity to present mainly the management challenges and solutions in the cooperation of science and business.
go to GlucoTab contribution
show the GlucoTab Science2Business Poster
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
